SCHEMBL10073049

SCHEMBL10073049

COc1ccc(C2(CNC(=O)c3ccco3)CCCC2)cc1OC

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.67
KDM4E B2RXH2 2/20 0.67
HTT P42858 2/20 0.67
MAPT P10636 2/20 0.67
HPGD P15428 1/20 0.67
NPC1 O15118 1/20 0.67
CYP1A2 P05177 1/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2C9 P11712 1/20 0.67
CYP2C19 P33261 1/20 0.67
LMNA P02545 3/20 0.66
CASP1 P29466 2/20 0.66
TSHR P16473 1/20 0.66
KMT2A Q03164 3/20 0.62
MEN1 O00255 2/20 0.62
TDP1 Q9NUW8 1/20 0.58
G6PD P11413 1/20 0.57
GAA P10253 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10073052 0.85 ALDH1A1 (0.83) ALDH1A1KDM4ELMNAKMT2AMEN1
SCHEMBL10073032 0.82 ALDH1A1 (0.72) ALDH1A1HTTLMNACASP1TSHR
SCHEMBL10073123 0.82 CASP1 (0.65) ALDH1A1KDM4EHTTMAPTHPGD
SCHEMBL10084140 0.82 ALDH1A1 (0.65) ALDH1A1KDM4EHTTMAPTHPGD
SCHEMBL10073048 0.82 LMNA (0.77) ALDH1A1HTTMAPTHPGDLMNA
SCHEMBL558577 0.81 L3MBTL1 (0.62) ALDH1A1KDM4EHTTMAPTHPGD
SCHEMBL558502 0.81 ALDH1A1 (0.70) ALDH1A1HTTLMNACASP1TSHR
SCHEMBL558061 0.81 L3MBTL1 (0.61) ALDH1A1KDM4EHTTMAPTHPGD
SCHEMBL8291466 0.81 ALDH1A1 (1.00) ALDH1A1KDM4EHTTMAPTHPGD
SCHEMBL10073125 0.80 CASP1 (0.62) ALDH1A1KDM4EHTTMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-10 US disclosed
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED 2012-02-09 US disclosed
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-20 US disclosed
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-20 US disclosed
US-7598412-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-10-06 US disclosed
US-7598412-B2 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012536-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS ABCB11, ABCB1, ABCC5 ALDH1A1 895/4885KDM4E 4529/4885HTT 751/4885
US-20100125090-A1 Modulators of ATP-Binding Cassette Transporters ABCB11, ABCB1, ABCC5 ALDH1A1 895/4885KDM4E 4529/4885HTT 751/4885
US-20120035179-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS ABCB11, ABCB1, ABCC5 ALDH1A1 895/4885KDM4E 4529/4885HTT 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.